Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析

◆英語タイトル:Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15486
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:86
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Abbott Laboratories (ABT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott Laboratories (Abbott) develops, manufactures and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities across the world. The company markets its products in North America, Latin America, the Caribbean, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Mar 19,2019 Abbott Announces CE Mark for Alinity m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Mar 17,2019 New Data for Abbott’s HeartMate 3(TM) Highlights Unparalleled Performance of Industry’s Leading Heart Pump
Mar 14,2019 FDA approves new indication for Abbott Vasculars heart valve repair device
Mar 11,2019 Decision to award market share for permanent coronary drug eluting stents to Abbott Laboratories NZ Limited

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Abbott Laboratories – Key Facts
Abbott Laboratories – Key Employees
Abbott Laboratories – Key Employee Biographies
Abbott Laboratories – Major Products and Services
Abbott Laboratories – History
Abbott Laboratories – Company Statement
Abbott Laboratories – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Abbott Laboratories – Business Description
Business Segment: Cardiovascular and Neuromodulation Products
Overview
Performance
Business Segment: Diagnostics
Overview
Performance
Business Segment: Established Pharmaceutical Products
Overview
Performance
Business Segment: Nutritionals
Overview
Performance
Business Segment: Others
Overview
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: China
Performance
Geographical Segment: India
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Netherlands
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: United States
Performance
R&D Overview
Abbott Laboratories – SWOT Analysis
SWOT Analysis – Overview
Abbott Laboratories – Strengths
Abbott Laboratories – Weaknesses
Abbott Laboratories – Opportunities
Abbott Laboratories – Threats
Abbott Laboratories – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Abbott Laboratories, Medical Equipment, Deals By Year, 2013 to YTD 2019
Abbott Laboratories, Medical Equipment, Deals By Type, 2013 to YTD 2019
Abbott Laboratories, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 19, 2019: Abbott Announces CE Mark for Alinity m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Mar 17, 2019: New Data for Abbott’s HeartMate 3(TM) Highlights Unparalleled Performance of Industry’s Leading Heart Pump
Mar 14, 2019: FDA approves new indication for Abbott Vasculars heart valve repair device
Mar 11, 2019: Decision to award market share for permanent coronary drug eluting stents to Abbott Laboratories NZ Limited
Mar 05, 2019: Abbott’s latest diagnostics technology, Alinity, selected by Regional Medical Laboratory to deliver benefits to hospitals and patients
Feb 25, 2019: Abbott to Present at Barclays Global Healthcare Conference
Feb 20, 2019: Abbott Introduces the World’s Most Sensitive Rapid Diagnostic Test, Determine HBsAg 2, to Accelerate Hepatitis B Care
Feb 20, 2019: Abbott and Novo Nordisk strike diabetes digital solution deal
Feb 19, 2019: United States joins false claims act lawsuit against Arriva Medical and Alere
Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Abbott Laboratories, Key Facts
Abbott Laboratories, Key Employees
Abbott Laboratories, Key Employee Biographies
Abbott Laboratories, Major Products and Services
Abbott Laboratories, History
Abbott Laboratories, Other Locations
Abbott Laboratories, Subsidiaries
Abbott Laboratories, Key Competitors
Abbott Laboratories, Ratios based on current share price
Abbott Laboratories, Annual Ratios
Abbott Laboratories, Annual Ratios (Cont...1)
Abbott Laboratories, Annual Ratios (Cont...2)
Abbott Laboratories, Interim Ratios
Abbott Laboratories, Medical Equipment, Deals By Year, 2013 to YTD 2019
Abbott Laboratories, Medical Equipment, Deals By Type, 2013 to YTD 2019
Abbott Laboratories, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Abbott Laboratories, Performance Chart (2014 - 2018)
Abbott Laboratories, Ratio Charts
Abbott Laboratories, Medical Equipment, Deals By Year, 2013 to YTD 2019
Abbott Laboratories, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Santander UK PLC:企業の戦略・SWOT・財務分析
    Santander UK PLC - Strategy, SWOT and Corporate Finance Report Summary Santander UK PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • EyeGate Pharmaceuticals Inc (EYEG):医療機器:M&Aディール及び事業提携情報
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • Manipal Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Manipal Hospital, formerly Manipal Health Systems is a healthcare service provider that offers primary, secondary and tertiary healthcare services. The hospital offers services such as robotic assisted surgery, eye care, rehabilitation, skin care, accident and emergency care, child care, den …
  • Petoro AS-石油・ガス分野:企業M&A・提携分析
    Summary Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state's direct …
  • Itron Inc (ITRI):企業の財務・戦略的SWOT分析
    Itron Inc (ITRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Petroleum Geo-Services ASA (PGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleum Geo-Services ASA (PGS) is a marine geophysical company. The company provides a wide range of products including seismic and electromagnetic services, data acquisition, processing, reservoir analysis/interpretation and MultiClient library data. Its MultiClient data library is among …
  • Obton AS:電力:M&Aディール及び事業提携情報
    Summary Obton A/S (Obton) is an investment company that offers management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and feed-in tar …
  • Etiqa Life and General Assurance Philippines Inc:企業の戦略・SWOT・財務分析
    Etiqa Life and General Assurance Philippines Inc - Strategy, SWOT and Corporate Finance Report Summary Etiqa Life and General Assurance Philippines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Mattress Firm Holding Corp.:企業のM&A・事業提携・投資動向
    Mattress Firm Holding Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mattress Firm Holding Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Peak Resources Ltd. (PEK):企業の財務・戦略的SWOT分析
    Peak Resources Ltd. (PEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chiyoda Corporation:企業の戦略・SWOT・財務情報
    Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report Summary Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Oil Refineries Ltd (ORL):企業の財務・戦略的SWOT分析
    Oil Refineries Ltd (ORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Water Intelligence PLC (WATR):企業の財務・戦略的SWOT分析
    Summary Water Intelligence plc (Water Intelligence) formerly Qonnectis Plc, is a clean technology company that offers environmental and technology services. The company offers services such as finding, detecting, and remediating water leaks services. It monitors and protects water infrastructure and …
  • Shibuya Kogyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SunPower Corporation:企業の戦略・SWOT・財務情報
    SunPower Corporation - Strategy, SWOT and Corporate Finance Report Summary SunPower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Eaton Corporation plc:戦略・SWOT・企業財務分析
    Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PHC Corp:医療機器:M&Aディール及び事業提携情報
    Summary PHC Corp (PHC), formerly Panasonic Healthcare Co Ltd, a subsidiary of PHC Holdings Corp, is a medical device company that provides vitro diagnostics, medical IT and life science equipment. The company provides biomedical systems such as preservation systems, incubation systems, sterilization …
  • SIFI SpA:企業の戦略的SWOT分析
    SIFI SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆